These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


260 related items for PubMed ID: 30086206

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. CD4+ T helper cells and regulatory T cells in active lupus nephritis: an imbalance towards a predominant Th1 response?
    Mesquita D, Kirsztajn GM, Franco MF, Reis LA, Perazzio SF, Mesquita FV, Ferreira VDS, Andrade LEC, de Souza AWS.
    Clin Exp Immunol; 2018 Jan; 191(1):50-59. PubMed ID: 28945272
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effect of induction therapy on circulating T-helper 17 and T-regulatory cells in active proliferative lupus nephritis.
    Shenoy S, Chaurasia S, Edavalath S, Zanwar A, Agrawal V, Aggarwal A, Misra R.
    Int J Rheum Dis; 2018 May; 21(5):1040-1048. PubMed ID: 29392921
    [Abstract] [Full Text] [Related]

  • 5. BTLA Expression on Th1, Th2 and Th17 Effector T-Cells of Patients with Systemic Lupus Erythematosus Is Associated with Active Disease.
    Oster C, Wilde B, Specker C, Sun M, Kribben A, Witzke O, Dolff S.
    Int J Mol Sci; 2019 Sep 11; 20(18):. PubMed ID: 31514450
    [Abstract] [Full Text] [Related]

  • 6. [Expression and significance of Th17 and Treg cells in peripheral blood of patients with systemic lupus erythematosus].
    Cai XY, Luo M, Lin XJ, Xu YL, Tang C, Ye JH, Li WN, He ZX, Yu N.
    Zhonghua Yi Xue Za Zhi; 2012 Feb 21; 92(7):460-3. PubMed ID: 22490966
    [Abstract] [Full Text] [Related]

  • 7. MicroRNA-10a-3p mediates Th17/Treg cell balance and improves renal injury by inhibiting REG3A in lupus nephritis.
    You G, Cao H, Yan L, He P, Wang Y, Liu B, Shao F.
    Int Immunopharmacol; 2020 Nov 21; 88():106891. PubMed ID: 32853927
    [Abstract] [Full Text] [Related]

  • 8. Peripheral blood Th17/Treg imbalance in patients with low-active systemic lupus erythematosus.
    Szmyrka-Kaczmarek M, Kosmaczewska A, Ciszak L, Szteblich A, Wiland P.
    Postepy Hig Med Dosw (Online); 2014 Nov 21; 68():893-8. PubMed ID: 24988609
    [Abstract] [Full Text] [Related]

  • 9. Role of Treg cells and TGF-β1 in patients with systemic lupus erythematosus: a possible relation with lupus nephritis.
    Xing Q, Su H, Cui J, Wang B.
    Immunol Invest; 2012 Nov 21; 41(1):15-27. PubMed ID: 21563925
    [Abstract] [Full Text] [Related]

  • 10. Clinical Remission of Sight-Threatening Non-Infectious Uveitis Is Characterized by an Upregulation of Peripheral T-Regulatory Cell Polarized Towards T-bet and TIGIT.
    Gilbert RM, Zhang X, Sampson RD, Ehrenstein MR, Nguyen DX, Chaudhry M, Mein C, Mahmud N, Galatowicz G, Tomkins-Netzer O, Calder VL, Lightman S.
    Front Immunol; 2018 Nov 21; 9():907. PubMed ID: 29774027
    [Abstract] [Full Text] [Related]

  • 11. Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity.
    Talaat RM, Mohamed SF, Bassyouni IH, Raouf AA.
    Cytokine; 2015 Apr 21; 72(2):146-53. PubMed ID: 25647269
    [Abstract] [Full Text] [Related]

  • 12. The regulation of the Treg/Th17 balance by mesenchymal stem cells in human systemic lupus erythematosus.
    Wang D, Huang S, Yuan X, Liang J, Xu R, Yao G, Feng X, Sun L.
    Cell Mol Immunol; 2017 May 21; 14(5):423-431. PubMed ID: 26435067
    [Abstract] [Full Text] [Related]

  • 13. CD4+  CD25+  GARP+ regulatory T cells display a compromised suppressive function in patients with dilated cardiomyopathy.
    Wei Y, Yu K, Wei H, Su X, Zhu R, Shi H, Sun H, Luo Q, Xu W, Xiao J, Zhong Y, Zeng Q.
    Immunology; 2017 Jul 21; 151(3):291-303. PubMed ID: 28207945
    [Abstract] [Full Text] [Related]

  • 14. Altered Th17/Treg Ratio in Peripheral Blood of Systemic Lupus Erythematosus but Not Primary Antiphospholipid Syndrome.
    Álvarez-Rodríguez L, Martínez-Taboada V, Calvo-Alén J, Beares I, Villa I, López-Hoyos M.
    Front Immunol; 2019 Jul 21; 10():391. PubMed ID: 30894863
    [Abstract] [Full Text] [Related]

  • 15. Immunosuppressive therapy influences the accelerated age-dependent T-helper cell differentiation in systemic lupus erythematosus remission patients.
    Schaier M, Gottschalk C, Uhlmann L, Speer C, Kälble F, Eckstein V, Müller-Tidow C, Meuer S, Mahnke K, Lorenz HM, Zeier M, Steinborn A.
    Arthritis Res Ther; 2018 Dec 18; 20(1):278. PubMed ID: 30563559
    [Abstract] [Full Text] [Related]

  • 16. Imbalance between Th17 and regulatory T-cells in systemic lupus erythematosus.
    Kleczynska W, Jakiela B, Plutecka H, Milewski M, Sanak M, Musial J.
    Folia Histochem Cytobiol; 2011 Dec 18; 49(4):646-53. PubMed ID: 22252759
    [Abstract] [Full Text] [Related]

  • 17. The potential role of Th17 cells and Th17-related cytokines in the pathogenesis of lupus nephritis.
    Chen DY, Chen YM, Wen MC, Hsieh TY, Hung WT, Lan JL.
    Lupus; 2012 Nov 18; 21(13):1385-96. PubMed ID: 22892208
    [Abstract] [Full Text] [Related]

  • 18. Akt-dependent enhanced migratory capacity of Th17 cells from children with lupus nephritis.
    Kshirsagar S, Riedl M, Billing H, Tönshoff B, Thangavadivel S, Steuber C, Staude H, Wechselberger G, Edelbauer M.
    J Immunol; 2014 Nov 15; 193(10):4895-903. PubMed ID: 25339666
    [Abstract] [Full Text] [Related]

  • 19. Exacerbation of lupus nephritis by high sodium chloride related to activation of SGK1 pathway.
    Yang X, Yao G, Chen W, Tang X, Feng X, Sun L.
    Int Immunopharmacol; 2015 Dec 15; 29(2):568-573. PubMed ID: 26474695
    [Abstract] [Full Text] [Related]

  • 20. Activity of childhood lupus nephritis is linked to altered T cell and cytokine homeostasis.
    Edelbauer M, Kshirsagar S, Riedl M, Billing H, Tönshoff B, Haffner D, Cortina G, Amon O, Ross S, Dötsch J, Wechselberger G, Weber LT, Dablander M, Anliker M, Griesmacher A, Steichen-Gersdorf E.
    J Clin Immunol; 2012 Jun 15; 32(3):477-87. PubMed ID: 22228566
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.